Streptococcus Pneumoniae Infection Clinical Trial
Official title:
A Controlled Human Pneumococcal Infection Model (PIM) Study
Infection with Streptococcus pneumoniae (the pneumococcus) is the leading cause of pneumonia, bacterial meningitis and bacteraemia worldwide in the very young and the elderly. Although pneumococcal vaccines exist, they do not provide complete protection and new strategies to combat this pathogen are urgently needed. Asymptomatic infection of S. pneumoniae in the human nasopharynx precedes the development of pneumococcal disease. Previously, an Experimental Human Pneumococcal Carriage (EHPC) model has been developed at the Liverpool School of Tropical Medicine (LSTM). The current study entails to establish this model in healthy adults living in the Netherlands using the inoculation dose currently used at LSTM. Healthy adult participants (M/F) will be inoculated intranasally with strain BHN418, a penicillin sensitive serotype 6B strain of S. pneumoniae that was previously isolated from a healthy carrier. Following inoculation, participants will be monitored and blood and nasal samples will be collected over a period of 28 ± 3 days. Participants will receive a course of amoxicillin to eradicate infection on or shortly after the last visit at day 28 ± 3, unless S. pneumoniae is not detected on both day 14 and 28 ± 3 post-inoculation.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05060146 -
Prevention of Pneumococcal Infections: Impact Collaborative Medico-pharmaceutical Care Structured to Improve Vaccination Coverage of Patients at Risk.
|
N/A | |
Not yet recruiting |
NCT05017519 -
Epidemiology and Household Transmission of Streptococcus Pneumoniae and Respiratory Syncytial Virus
|
||
Recruiting |
NCT05759520 -
Phase III Clinical Trial of 13-valent Pneumococcal Conjugate Vaccine (Multivalent Conjugate) in Infants
|
Phase 3 | |
Active, not recruiting |
NCT03489018 -
The Effect of Fractional Doses of Pneumococcal Conjugate Vaccines on Immunogenicity and Carriage in Kenyan Infants
|
Phase 4 | |
Completed |
NCT03696303 -
Determination of the Utility of Pfizer's Pneumococcal Urine Antigen Test in Children 5 Years of Age or Younger With Community Acquired Pneumonia in Guatemala
|
||
Active, not recruiting |
NCT03102840 -
Understanding Pneumococcal Carriage and Disease 2017-2020
|
||
Completed |
NCT00189020 -
Effect of Two Versus Three Pneumococcal Conjugate Vaccinations
|
Phase 3 | |
Completed |
NCT02037984 -
Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-004)
|
Phase 1/Phase 2 | |
Recruiting |
NCT04944719 -
Pneumococcal Nasopharyngeal Colonization as Predictor of Community-Acquired Pneumonia (CAP) in Adults With Chronic Diseases.
|
||
Completed |
NCT03384589 -
CIRN Pneumococcal Conjugate Vaccine 1 vs. 2 Dose Priming Study
|
Phase 2/Phase 3 |